Halozyme reports US FDA approval of TECVAYLI in combination with DARZALEX FASPRO for relapsed/refractory multiple myeloma
9 March 2026 - US biopharmaceutical company Halozyme Therapeutics Inc (NASDAQ:HALO) announced on Friday that Johnson & Johnson (J&J) (NYSE:JNJ) has received approval from the US Food and Drug ...